tiprankstipranks
Affimed Faces Growing Losses Amid Financial Struggles
Company Announcements

Affimed Faces Growing Losses Amid Financial Struggles

Affimed (AFMD) has released an update.

Pick the best stocks and maximize your portfolio:

Affimed N.V. reported increased losses for the third quarter of 2024, with a comprehensive loss of €15.1 million compared to €24.4 million in the same period in 2023. The company’s assets have significantly decreased, impacting its financial standing, while research and development expenses remain high. Investors should closely watch how Affimed navigates these financial challenges.

For further insights into AFMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAffimed price target lowered to $11 from $15 at Wells Fargo
TheFlyAffimed price target lowered to $7 from $10 at H.C. Wainwright
TipRanks Auto-Generated NewsdeskAffimed’s Promising Clinical Update on NSCLC Treatment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App